Evaluation of the activity of bispirazoles against recombinant Trypanosoma cruzi strains expressing ß-galactosidase
Background: Nifurtimox and benznidazole are the only drugs currently approved to treat Chagas disease, caused Trypanosoma cruzi. However, they display unsatisfactory efficacy and induce undesirable side effects. Therefore, identifying new compounds with specific activity against T. cruzi is of great...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | article |
| Publicado: |
2023
|
| Subjects: | |
| Acceso en liña: | https://repositorio.puce.edu.ec/handle/123456789/43351 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Engadir etiqueta 
